human anti-d immunoglobulin

It is used to prevent Rh(D) immunization in women with Rh(D) negative blood group. This occurs during pregnancy (either planned or following complications such as miscarriage, hemorrhage, or invasive procedures) and after the birth of an Rh(D) positive child. It is also indicated for treating Rh(D) negative individuals who have received incompatible blood transfusions.

Form: solution for injection

ATC: J06BB01

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to prevent immunization against the Rhesus D factor in Rh(D)-negative women. Specifically, it is used during pregnancy (both as scheduled prophylaxis and in case of complications), after the birth of an Rh(D)-positive child, and in the event of accidental transfusions of incompatible blood.

Form: solution for injection, powder and solvent

ATC: J06BB01

Manufacturer: KEDRION S.P.A.

It is used to prevent immunization in Rh-negative women during pregnancy and childbirth, thereby protecting the fetus from potential harm. It is indicated in cases such as the birth of an Rh-positive baby, miscarriages, ectopic pregnancies, invasive procedures during pregnancy (such as amniocentesis), abdominal trauma, or in the event of accidental Rh-positive blood transfusions.

Form: solution for injection

ATC: J06BB01

Manufacturer: OCTAPHARMA ITALY S.P.A.